NCT00996346 arm group 7ae12900f669b6ab9982c884244ca280 [clinicaltrials_resource:NCT00996346/arm-group/7ae12900f669b6ab9982c884244ca280]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00996346 arm group 7ae12900f669b6ab9982c884244ca280 [clinicaltrials_resource:NCT00996346/arm-group/7ae12900f669b6ab9982c884244ca280]
Bio2RDF identifier
NCT00996346/arm-group/7ae12900f669b6ab9982c884244ca280
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... e12900f669b6ab9982c884244ca280
description [clinicaltrials_vocabulary:description]
Temsirolimus 25 mg weekly x3; Level 3 Irinotecan 80 mg/m2 weekly x3
identifier
clinicaltrials_resource:NCT00996346/arm-group/7ae12900f669b6ab9982c884244ca280
title
NCT00996346 arm group 7ae12900f669b6ab9982c884244ca280
@en
type
label
NCT00996346 arm group 7ae12900 ...... 12900f669b6ab9982c884244ca280]
@en